Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP
Report ID | 86939 |
Drug Identification Number | 01933345 |
Brand name | AMPICILLIN SODIUM FOR INJECTION, USP |
Common or Proper name | AMPICILLIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMPICILLIN |
Strength(s) | 1000MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-06-18 |
Estimated end date | 2019-09-30 |
Actual end date | 2019-09-18 |
Shortage status | Resolved |
Updated date | 2019-09-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-09-19 | French | Compare |
v10 | 2019-09-19 | English | Compare |
v9 | 2019-08-29 | French | Compare |
v8 | 2019-08-29 | English | Compare |
v7 | 2019-08-06 | French | Compare |
v6 | 2019-08-06 | English | Compare |
v5 | 2019-07-15 | French | Compare |
v4 | 2019-07-15 | English | Compare |
v3 | 2019-06-19 | English | Compare |
v2 | 2019-06-18 | French | Compare |
v1 | 2019-06-18 | English | Compare |
Showing 1 to 11 of 11